Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Treatment outcomes of systemic chemotherapy for peritoneal carcinomatosis arising from gastric cancer with no measurable disease: retrospective analysis from a single center.

Hong SH, Shin YR, Roh SY, Jeon EK, Song KY, Park CH, Jeon HM, Hong YS.

Gastric Cancer. 2013 Jul;16(3):290-300. doi: 10.1007/s10120-012-0182-1. Epub 2012 Aug 17.

PMID:
22898806
2.

Outcome data of patients with peritoneal carcinomatosis from gastric origin treated by a strategy of bidirectional chemotherapy prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a single specialized center in Japan.

Canbay E, Mizumoto A, Ichinose M, Ishibashi H, Sako S, Hirano M, Takao N, Yonemura Y.

Ann Surg Oncol. 2014 Apr;21(4):1147-52. doi: 10.1245/s10434-013-3443-2. Epub 2013 Dec 20.

PMID:
24356799
3.

Survival benefit of palliative gastrectomy in gastric cancer patients with peritoneal metastasis.

Tokunaga M, Terashima M, Tanizawa Y, Bando E, Kawamura T, Yasui H, Boku N.

World J Surg. 2012 Nov;36(11):2637-43. doi: 10.1007/s00268-012-1721-y.

PMID:
22820871
4.

Neoadjuvant intraperitoneal and systemic chemotherapy for gastric cancer patients with peritoneal dissemination.

Fujiwara Y, Takiguchi S, Nakajima K, Miyata H, Yamasaki M, Kurokawa Y, Okada K, Mori M, Doki Y.

Ann Surg Oncol. 2011 Dec;18(13):3726-31. doi: 10.1245/s10434-011-1770-8. Epub 2011 May 17.

PMID:
21584835
5.

Intraoperatively assessed macroscopic serosal changes in patients with curatively resected advanced gastric cancer: clinical implications for prognosis and peritoneal recurrence.

Yoo C, Ryu MH, Park YS, Yoo MW, Park SR, Ryoo BY, Jang SJ, Yook JH, Kim BS, Kang YK.

Ann Surg Oncol. 2015 Sep;22(9):2940-7. doi: 10.1245/s10434-014-4352-8. Epub 2015 Jan 21.

PMID:
25605515
6.

Improving trends in survival of patients who receive chemotherapy for metastatic or recurrent gastric cancer: 12 years of experience at a single institution.

Koo DH, Ryu MH, Ryoo BY, Seo J, Lee MY, Chang HM, Lee JL, Lee SS, Kim TW, Kang YK.

Gastric Cancer. 2015 Apr;18(2):346-53. doi: 10.1007/s10120-014-0385-8. Epub 2014 May 16.

PMID:
24832201
7.

Effect of complication grade on survival following curative gastrectomy for carcinoma.

Jiang N, Deng JY, Ding XW, Zhang L, Liu HG, Liang YX, Liang H.

World J Gastroenterol. 2014 Jul 7;20(25):8244-52. doi: 10.3748/wjg.v20.i25.8244.

PMID:
25009399
8.

Adjuvant chemotherapy, p53, carcinoembryonic antigen expression and prognosis after D2 gastrectomy for gastric adenocarcinoma.

He MM, Zhang DS, Wang F, Wang ZQ, Luo HY, Ren C, Jin Y, Chen DL, Xu RH.

World J Gastroenterol. 2014 Jan 7;20(1):264-73. doi: 10.3748/wjg.v20.i1.264.

PMID:
24415881
9.

Weekly paclitaxel as second-line chemotherapy in Japanese patients with advanced gastric cancer.

Kadokura M, Iwasa S, Honma Y, Kato K, Hamaguchi T, Yamada Y, Enomoto N, Shimada Y.

Anticancer Res. 2013 Oct;33(10):4547-52.

PMID:
24123029
10.

Factors correlated with peritoneal carcinomatosis and survival in patients with gastric cancer treated at a single institution in Brazil.

Fanelli MF, Silva MJ, de Paiva TF Jr, Chinen LT, Guimarães AP, Gimenes DL, Pinheiro ED, Rinck JA Jr, Nicolau UR, Sanches SM, Melo CA, Dettino AL, Cruz MR, de Melo LM, Formiga MN, de Lima VC.

Int J Clin Oncol. 2009 Aug;14(4):326-31. doi: 10.1007/s10147-008-0870-3. Epub 2009 Aug 25.

PMID:
19705243
11.

The effect of the gastrectomy on survival in patients with metastatic gastric cancer: a study of ASMO.

Yazıcı O, Özdemir N, Duran AO, Menekşe S, Şendur MA, Karaca H, Göksel G, Arpacı E, Hacıbekiroğlu İ, Bilgetekin İ, Kaçan T, Özkan M, Aksoy S, Aksoy A, Çokmert S, Uysal M, Elkıran ET, Çiçin İ, Büyükberber S, Zengin N.

Future Oncol. 2016 Feb;12(3):343-54. doi: 10.2217/fon.15.304. Epub 2016 Jan 18. Erratum in: Future Oncol. 2016 Mar;12(6):881.

PMID:
26775722
12.

Chemoresponse after non-curative gastrectomy for M1 gastric cancer.

Shin HB, Lee SH, Son YG, Ryu SW, Sohn SS.

World J Surg Oncol. 2015 Jan 30;13:13. doi: 10.1186/s12957-015-0447-3.

PMID:
25634223
13.

Retrospective analysis of adjuvant intraperitoneal chemotherapy effect prognosis of resectable gastric cancer.

Shi C, Yang B, Chen Q, Yang J, Fan N.

Oncology. 2011;80(5-6):289-95. doi: 10.1159/000329075. Epub 2011 Jul 18.

PMID:
21778768
14.

Intraperitoneal docetaxel combined with S-1 for advanced gastric cancer with peritoneal dissemination.

Fujiwara Y, Takiguchi S, Nakajima K, Miyata H, Yamasaki M, Kurokawa Y, Mori M, Doki Y.

J Surg Oncol. 2012 Jan;105(1):38-42. doi: 10.1002/jso.22057. Epub 2011 Aug 31.

PMID:
21882194
15.

Combination chemotherapy with capecitabine (X) and Cisplatin (P) as first line treatment in advanced gastric cancer: experience of 223 patients with prognostic factor analysis.

Lee SS, Lee JL, Ryu MH, Chang HM, Kim TW, Kang HJ, Kim WK, Lee JS, Kang YK.

Jpn J Clin Oncol. 2007 Jan;37(1):30-7.

PMID:
17272321
16.

Neoadjuvant treatment of gastric cancer with peritoneal dissemination.

Yonemura Y, Bandou E, Sawa T, Yoshimitsu Y, Endou Y, Sasaki T, Sugarbaker PH.

Eur J Surg Oncol. 2006 Aug;32(6):661-5. Epub 2006 Apr 18.

PMID:
16621433
17.

Should patients with peritoneal carcinomatosis of colorectal origin with synchronous liver metastases be treated with a curative intent? A case-control study.

Maggiori L, Goéré D, Viana B, Tzanis D, Dumont F, Honoré C, Eveno C, Elias D.

Ann Surg. 2013 Jul;258(1):116-21. doi: 10.1097/SLA.0b013e3182778089.

PMID:
23207243
18.

Prognostic significance of non-curative gastrectomy for incurable gastric carcinoma.

Jeong O, Park YK, Choi WY, Ryu SY.

Ann Surg Oncol. 2014 Aug;21(8):2587-93. doi: 10.1245/s10434-014-3638-1. Epub 2014 Mar 17.

PMID:
24633671
19.

Palliative distal gastrectomy offers no survival benefit over gastrojejunostomy for gastric cancer with outlet obstruction: retrospective analysis of an 11-year experience.

Okumura Y, Yamashita H, Aikou S, Yagi K, Yamagata Y, Nishida M, Mori K, Nomura S, Kitayama J, Watanabe T, Seto Y.

World J Surg Oncol. 2014 Nov 29;12:364. doi: 10.1186/1477-7819-12-364.

PMID:
25432703
20.

Benefits of intra-operative systemic chemotherapy during curative surgery in patients with locally advanced gastric cancer.

Meng QB, Yu JC, Ma ZQ, Kang WM, Zhou L, Ye X.

Chin Med J (Engl). 2013;126(18):3493-8.

PMID:
24034096

Supplemental Content

Support Center